Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gigacloud Technology Inc (GCT) vs 10X Genomics Inc (TXG) Price & Performance

Gigacloud Technology IncTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Gigacloud Technology Inc vs 10X Genomics Inc — how do they compare? Gigacloud Technology Inc trades at $51 (market cap $1.84B), while 10X Genomics Inc trades at $59.24 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 4.1× Gigacloud Technology Inc's market cap. Which is the better fit depends on your goals.

GCTTXG
Market Cap
$1.84B$7.61B
Sector
TechnologyHealth
52-Week High
$53.25$58.57
52-Week Low
$25.44$11.34
Enterprise Value
$1.97B$7.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gigacloud Technology Inc

GCT trades at $53.25, up 1.62% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats, including Q2 2026 EPS of $1.16 versus $0.90 expected, and maintains a 10.65% net income margin. Revenue growth is projected from $1.29B in 2025 to $1.5B in 2026, supported by positive cash flow generation of $120.10M in 2025.

The outlook remains positive given strong profitability metrics (32.34% ROE) and analyst consensus favoring Buy ratings (66.67%). Key risks include potential margin pressure from higher costs and competitive threats in the B2B logistics space. The stock's current valuation at 12.3x P/E appears reasonable relative to growth prospects, though technical indicators show overbought conditions with RSI above 85.

10X Genomics Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Gigacloud Technology Inc

Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.

Read more on GCT

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG